MeSH Review:
Muscular Atrophy
Robertson,
Crocker,
Nicholson,
Schulz,
Jaksch,
Horvath,
Horn,
Auer,
Macmillan,
Peters,
Gerbitz,
Kraegeloh-Mann,
Muntau,
Karcagi,
Kalmanchey,
Lochmuller,
Shoubridge,
Freisinger,
Rittweger,
Frost,
Schiessl,
Ohshima,
Alkner,
Tesch,
Felsenberg,
Jarecki,
Chen,
Bernardino,
Coovert,
Whitney,
Burghes,
Stack,
Pollok,
Merry,
Kobayashi,
Bailey,
Taye,
Fischbeck,
Bodine,
Stitt,
Gonzalez,
Kline,
Stover,
Bauerlein,
Zlotchenko,
Scrimgeour,
Lawrence,
Glass,
Yancopoulos,
- Triplet repeat mutations in human disease. Caskey, C.T., Pizzuti, A., Fu, Y.H., Fenwick, R.G., Nelson, D.L. Science (1992)
- Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J., Yancopoulos, G.D. Nat. Cell Biol. (2001)
- Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Takeyama, K., Ito, S., Yamamoto, A., Tanimoto, H., Furutani, T., Kanuka, H., Miura, M., Tabata, T., Kato, S. Neuron (2002)
- Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Merry, D.E., Kobayashi, Y., Bailey, C.K., Taye, A.A., Fischbeck, K.H. Hum. Mol. Genet. (1998)
- Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Jarecki, J., Chen, X., Bernardino, A., Coovert, D.D., Whitney, M., Burghes, A., Stack, J., Pollok, B.A. Hum. Mol. Genet. (2005)
- Trinucleotide repeat expansions and human genetic disease. Bates, G., Lehrach, H. Bioessays (1994)
- The growth factor myostatin, a key regulator in skeletal muscle growth and homeostasis. Matsakas, A., Diel, P. International journal of sports medicine. (2005)
- IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cai, D., Frantz, J.D., Tawa, N.E., Melendez, P.A., Oh, B.C., Lidov, H.G., Hasselgren, P.O., Frontera, W.R., Lee, J., Glass, D.J., Shoelson, S.E. Cell (2004)
- Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S.H., Goldberg, A.L. Cell (2004)
- Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Mhatre, A.N., Trifiro, M.A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G., Pinsky, L. Nat. Genet. (1993)
- Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Katsuno, M., Adachi, H., Doyu, M., Minamiyama, M., Sang, C., Kobayashi, Y., Inukai, A., Sobue, G. Nat. Med. (2003)
- Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M., Sobue, G. Neuron (2002)
- Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat. Ruff, R.L., Secrist, D. J. Clin. Invest. (1984)
- Forearm 3-methylhistidine efflux in myotonic dystrophy. Rifai, Z., Kingston, W.J., McCraith, B., Moxley, R.T. Ann. Neurol. (1993)
- Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Van Belle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., Isner, J.M. Circulation (1998)
- Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level. Tanaka, F., Reeves, M.F., Ito, Y., Matsumoto, M., Li, M., Miwa, S., Inukai, A., Yamamoto, M., Doyu, M., Yoshida, M., Hashizume, Y., Terao, S., Mitsuma, T., Sobue, G. Am. J. Hum. Genet. (1999)
- Founder effect in spinal and bulbar muscular atrophy (SBMA). Tanaka, F., Doyu, M., Ito, Y., Matsumoto, M., Mitsuma, T., Abe, K., Aoki, M., Itoyama, Y., Fischbeck, K.H., Sobue, G. Hum. Mol. Genet. (1996)
- Neuroprotection by the inhibition of apoptosis. Robertson, G.S., Crocker, S.J., Nicholson, D.W., Schulz, J.B. Brain Pathol. (2000)
- Reduced androgen receptor gene expression with first exon CAG repeat expansion. Choong, C.S., Kemppainen, J.A., Zhou, Z.X., Wilson, E.M. Mol. Endocrinol. (1996)
- Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Cox, G.A., Mahaffey, C.L., Frankel, W.N. Neuron (1998)
- Neurotrophin-3-enhanced nerve regeneration selectively improves recovery of muscle fibers expressing myosin heavy chains 2b. Sterne, G.D., Coulton, G.R., Brown, R.A., Green, C.J., Terenghi, G. J. Cell Biol. (1997)
- Defective satellite cells in congenital myotonic dystrophy. Furling, D., Coiffier, L., Mouly, V., Barbet, J.P., St Guily, J.L., Taneja, K., Gourdon, G., Junien, C., Butler-Browne, G.S. Hum. Mol. Genet. (2001)
- CAG repeat length variation in sperm from a patient with Kennedy's disease. Zhang, L., Fischbeck, K.H., Arnheim, N. Hum. Mol. Genet. (1995)
- Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., Monden, M. J. Clin. Invest. (1996)
- The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. Hsiao, P.W., Lin, D.L., Nakao, R., Chang, C. J. Biol. Chem. (1999)
- A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1). Nazareth, L.V., Stenoien, D.L., Bingman, W.E., James, A.J., Wu, C., Zhang, Y., Edwards, D.P., Mancini, M., Marcelli, M., Lamb, D.J., Weigel, N.L. Mol. Endocrinol. (1999)
- Homozygosity (E140K) in SCO2 causes delayed infantile onset of cardiomyopathy and neuropathy. Jaksch, M., Horvath, R., Horn, N., Auer, D.P., Macmillan, C., Peters, J., Gerbitz, K.D., Kraegeloh-Mann, I., Muntau, A., Karcagi, V., Kalmanchey, R., Lochmuller, H., Shoubridge, E.A., Freisinger, P. Neurology (2001)
- Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Mohajeri, M.H., Figlewicz, D.A., Bohn, M.C. Hum. Gene Ther. (1999)
- Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ikeda, K., Klinkosz, B., Greene, T., Cedarbaum, J.M., Wong, V., Lindsay, R.M., Mitsumoto, H. Ann. Neurol. (1995)
- Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study. Rittweger, J., Frost, H.M., Schiessl, H., Ohshima, H., Alkner, B., Tesch, P., Felsenberg, D. Bone (2005)
- Time course of muscle atrophy and recovery following a phenol-induced nerve block. Bodine-Fowler, S.C., Allsing, S., Botte, M.J. Muscle Nerve (1996)
- Evidence for down-regulation of GAP-43 mRNA in Wobbler mouse spinal motoneurons by corticosterone and a 21-aminosteroid. González Deniselle, M.C., Grillo, C.A., González, S., Roig, P., De Nicola, A.F. Brain Res. (1999)
- Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Appell, H.J., Duarte, J.A., Soares, J.M. International journal of sports medicine. (1997)